Skip to main content
. Author manuscript; available in PMC: 2014 Sep 19.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Mar 17;(3):CD006654. doi: 10.1002/14651858.CD006654.pub2
Trial name or title A1281014
Methods Allocation: random, no further details.
Blindness: double, double-dummy.
Duration: 12 weeks.
Design: parallel.
Location: multicentre.
Setting: not reported.
Participants Diagnosis: schizophrenia or schizoaffective disorder.
N=not reported.
Sex: not reported.
Age: not reported.
History: duration ill not reported, age at onset not reported
Interventions 1. Olanzapine:
Fixed/flexible dose: not reported.
Allowed dose range: not reported.
Mean dose: not reported.
N=not reported.
2. Ziprasidone:
Fixed/flexible dose: not reported.
Allowed dose range: not reported.
Mean dose: not reported.
N=not reported.
Outcomes not reported.
Starting date 6 October 2000.
Contact information Prof Ann Mortimer
Coniston House
East Riding Campus
Willerby
HU10 6NS
UK
Telephone: 01482 466700
A.M.Mortimer@medschool.hull.ac.uk
Notes